Michael James McClellan, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 230 shares at $16.63 ($4K) on 2019-03-18, disclosed to the SEC on 2019-03-19.
Scheduled sale ($4k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TEVA | SELL | 2019-03-05 | $6K | — | Filing → |
| TEVA | SELL | 2018-11-07 | $8K | — | Filing → |
| TEVA | SELL | 2018-03-20 | $5K | — | Filing → |